Logo
N

Novoron Bioscience

13 employees

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Glaucoma
Neuronal regeneration
Tauopathy
Multiple Sclerosis
Pharmaceuticals
LDLR
CTE
Spinal cord injury
Neuroscience
Stroke
Paralysis
Remyelination
TBI
Alzheimer's disease

Date founded

2014

Funding rounds raised

Total raised

$3M

from 3 investors over 3 rounds

N

Novoron Bioscience raised undisclosed on January 28, 2022

Investors: National Institutes of Health

N

Novoron Bioscience raised $3M on November 16, 2021

Investors: Two Bear Capital

N

Novoron Bioscience raised undisclosed on March 3, 2018

Investors: Backstage Capital

FAQ